TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank80
3Y CAGR+11.8%
5Y CAGR+259.5%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+11.8%/yr
Annual compound
5Y CAGR
+259.5%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
600.3x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$65.13M+5.9%
2024$61.49M-12.6%
2023$70.38M+51.1%
2022$46.58M+49.1%
2021$31.24M+28694.5%
2020$108493.00-